Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging

Pınar Pelin Özcan; Zehra Pınar Koç; Gökçe Yavan; Mustafa Musa Dirlik

Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging

Abstract

Von Hippel–Lindau disease (VHL), also known as Von Hippel–Lindau syndrome, is a rare genetic disorder with multisystem involvement (1). Imaging plays an important role in the evaluation of cancer patients. In recent years, much attention has been focused on 68Ga-PSMA PET-CT. We hereby, report the rare case of a Von Hippel Lindau Syndrome with renal cell carcinoma, pancreas cystadenoma, hemangioblastoma and pancreatic NET demonstrated on both Ga-68 PSMA and FDG PET-CT imaging.

Keywords

References

1. Von Hippel-Lindau disease, Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-04-17
2. Lindsay, Kenneth W; Ian Bone; Robin Callander; J. van Gijn (1991). Neurology and Neurosurgery Illustrated. United States: Churchill Livingstone. ISBN 978-0-443-04345-1
3. Frantzen, Carlijn; Links, Thera P.; Giles, Rachel H. (21 June 2012). "Von Hippel-Lindau Syndrome". Von Hippel-Lindau Disease. GeneReviews at NCBI. University of Washington, Seattle. Retrieved 30 March 2013
4. Maher ER; Glenn GM; Walther M; et al. (June 2011). "von Hippel-Lindau disease: a clinical and scientific review". European Journal of Human Genetics. 19 (6): 617–23
5. Friedrich, CA (December 1, 1999). "Von Hippel-Lindau syndrome. A pleomorphic condition". Cancer. 86 (11 Suppl): 2478–82
6. Leung RS, Biswas SV, Duncan M, et al. Imaging features of von Hippel-Lindau disease. Radiographics. 2008; 28:65–67
7. Ambrosini V, Campana D, Allegri V, et al. 68Ga-DOTANOC PET/CT detects somatostatin receptors expression in von Hippel-Lindau cerebellar disease. Clin. Nucl. Med. 2011; 36:64–65.
8. Oh JR, Kulkarni H, Carreras C, et al. Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease. Nucl. Med. Mol. Imaging. 2012; 46:129–133

Details

Primary Language

English

Subjects

Oncology and Carcinogenesis

Journal Section

Image Presentation

Authors

Pınar Pelin Özcan ^* This is me
0000-0003-0147-2678
Türkiye

Zehra Pınar Koç This is me
0000-0002-3274-5790
Türkiye

Gökçe Yavan This is me
0000-0002-7332-6293
Türkiye

Mustafa Musa Dirlik This is me
0000-0002-5326-2149
Türkiye

Publication Date

April 15, 2022

Submission Date

March 10, 2022

Acceptance Date

April 14, 2022

Published in Issue

Year 2022 Volume: 2 Number: 1

IZ

https://izlik.org/JA23HJ32SX

Cite

RIS / Bibtex

APA

Özcan, P. P., Koç, Z. P., Yavan, G., & Dirlik, M. M. (2022). Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging. Molecular Oncologic Imaging, 2(1), 12-16. https://izlik.org/JA23HJ32SX

AMA

1.Özcan PP, Koç ZP, Yavan G, Dirlik MM. Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging. Molecular Oncologic Imaging. 2022;2(1):12-16. https://izlik.org/JA23HJ32SX

Chicago

Özcan, Pınar Pelin, Zehra Pınar Koç, Gökçe Yavan, and Mustafa Musa Dirlik. 2022. “Von Hippel Lindau Syndrome With Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging”. Molecular Oncologic Imaging 2 (1): 12-16. https://izlik.org/JA23HJ32SX.

EndNote

Özcan PP, Koç ZP, Yavan G, Dirlik MM (April 1, 2022) Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging. Molecular Oncologic Imaging 2 1 12–16.

IEEE

[1]P. P. Özcan, Z. P. Koç, G. Yavan, and M. M. Dirlik, “Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging”, Molecular Oncologic Imaging, vol. 2, no. 1, pp. 12–16, Apr. 2022, [Online]. Available: https://izlik.org/JA23HJ32SX

ISNAD

Özcan, Pınar Pelin - Koç, Zehra Pınar - Yavan, Gökçe - Dirlik, Mustafa Musa. “Von Hippel Lindau Syndrome With Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging”. Molecular Oncologic Imaging 2/1 (April 1, 2022): 12-16. https://izlik.org/JA23HJ32SX.

JAMA

1.Özcan PP, Koç ZP, Yavan G, Dirlik MM. Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging. Molecular Oncologic Imaging. 2022;2:12–16.

MLA

Özcan, Pınar Pelin, et al. “Von Hippel Lindau Syndrome With Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging”. Molecular Oncologic Imaging, vol. 2, no. 1, Apr. 2022, pp. 12-16, https://izlik.org/JA23HJ32SX.

Vancouver

1.Pınar Pelin Özcan, Zehra Pınar Koç, Gökçe Yavan, Mustafa Musa Dirlik. Von Hippel Lindau Syndrome with Renal Cell Carcinoma, Pancreas Serous Cystadenoma, Hemangioblastoma and NET Demonstrated on Ga-68 DOTATATE PET-CT and FDG PET-CT Imaging. Molecular Oncologic Imaging [Internet]. 2022 Apr. 1;2(1):12-6. Available from: https://izlik.org/JA23HJ32SX